MCM
ANGO icon

Massar Capital Management’s AngioDynamics ANGO Stock Holding History

Massar Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-28,000
Closed -$278K – 179
2025
Q2 		$278K Buy
+28,000
New +$274K 0.21% 90

Other funds holding ANGO

DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Massar Capital Management's ANGO Position: Q3 2025 in Review

Massar Capital Management sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 28,000 shares — an estimated $278K sold.

Massar Capital Management first reported a position in ANGO in Q2 2025 and held it in 1 quarter. The position peaked at $278K in Q2 2025. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • Massar Capital Management reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
  • Massar Capital Management sold 28,000 AngioDynamics shares in Q3 2025, an estimated $278K.
  • Massar Capital Management first reported a position in AngioDynamics in Q2 2025 and held it in 1 quarter.
  • Massar Capital Management's AngioDynamics position peaked at $278K in Q2 2025.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Massar Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.